Feb 12 |
Steven Cohen's Point72 Asset Management Acquires New Stake in Vaccinex Inc
|
Feb 7 |
Vaccinex prices $3.7M PIPE financing
|
Feb 7 |
Vaccinex Announces Pricing of $3.7 Million PIPE Financing
|
Jan 10 |
Vaccinex files to sell 712,484 shares for holders
|
Dec 4 |
Vaccinex says Nasdaq gives co extension to regain compliance with listing rule
|
Dec 4 |
Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule
|
Nov 13 |
Vaccinex GAAP EPS of -$1.09, revenue of $0.02M
|
Nov 13 |
Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update
|
Oct 26 |
Vaccinex Reports Positive Effect of Pepinemab Treatment on New Biomarker of Brain Inflammation in Neurodegenerative Diseases
|
Sep 29 |
Vaccinex slumps 29%, prices $9.6M equity
|